Anticancer Bioactive Peptide-3 Inhibits Human Gastric Cancer Growth by Suppressing Gastric Cancer Stem Cells

2014 ◽  
Vol 115 (4) ◽  
pp. 697-711 ◽  
Author(s):  
Lan Yu ◽  
Ling Yang ◽  
Wei An ◽  
Xiulan Su
Keyword(s):  
Gastric Cancer ◽  
Stem Cells ◽  
Cancer Stem Cells ◽  
Bioactive Peptide ◽  
Cancer Growth ◽  
Human Gastric Cancer ◽  
Gastric Cancer Stem Cells

M1998 Identification of Human Gastric-Cancer Stem Cells

2008 ◽  
Vol 134 (4) ◽  
pp. A-447
Author(s):  
M. Puglisi ◽  
N. Saulnier ◽  
A. Sgambato ◽  
M. Barba ◽  
Ernesto Cristiano Lauritano ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Stem Cells ◽  
Cancer Stem Cells ◽  
Human Gastric Cancer ◽  
Gastric Cancer Stem Cells

OC3.06.2 COULD CD133 BE USED AS MOLECULAR MARKER TO IDENTIFY HUMAN GASTRIC-CANCER STEM CELLS?

2008 ◽  
Vol 40 ◽  
pp. S52
Author(s):  
M.A. Puglisi ◽  
N. Saulnier ◽  
A. Sgambato ◽  
M. Barba ◽  
F. Rafanelli ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Stem Cells ◽  
Cancer Stem Cells ◽  
Molecular Marker ◽  
Human Gastric Cancer ◽  
Gastric Cancer Stem Cells

scholarly journals Resveratrol Analog 4-Bromo-Resveratrol Inhibits Gastric Cancer Stemness through the SIRT3-c-Jun N-Terminal Kinase Signaling Pathway

2021 ◽  
Vol 44 (1) ◽  
pp. 63-72
Author(s):  
Yun-Shen Tai ◽  
Yi-Shih Ma ◽  
Chun-Lin Chen ◽  
Hsin-Yi Tsai ◽  
Chin-Chuan Tsai ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Stem Cells ◽  
Cancer Stem Cells ◽  
Therapeutic Option ◽  
Mitochondrial Protein ◽  
Human Gastric Cancer ◽  
Gastric Cancer Cells ◽  
Therapeutic Drugs ◽  
Gastric Cancer Treatment ◽  
Gastric Cancer Stem Cells

Chemotherapy is the treatment of choice for gastric cancer, but the currently available therapeutic drugs have limited efficacy. Studies have suggested that gastric cancer stem cells may play a key role in drug resistance in chemotherapy. Therefore, new agents that selectively target gastric cancer stem cells in gastric tumors are urgently required. Sirtuin-3 (SIRT3) is a deacetylase that regulates mitochondrial metabolic homeostasis to maintain stemness in glioma stem cells. Targeting the mitochondrial protein SIRT3 may provide a novel therapeutic option for gastric cancer treatment. However, the mechanism by which stemness is regulated through SIRT3 inhibition in gastric cancer remains unknown. We evaluated the stemness inhibition ability of the SIRT3 inhibitor 4′-bromo-resveratrol (4-BR), an analog of resveratrol in human gastric cancer cells. Our results suggested that 4-BR inhibited gastric cancer cell stemness through the SIRT3-c-Jun N-terminal kinase pathway and may aid in gastric cancer stem-cell–targeted therapy.

Increased Production of Matrix Metalloproteinases in Helicobacter pylori Infection that Stimulates Gastric Cancer Stem Cells

2020 ◽  
Keyword(s):  
Gastric Cancer ◽  
Stem Cells ◽  
Helicobacter Pylori ◽  
Cancer Stem Cells ◽  
Histopathological Examination ◽  
Physiological Saline ◽  
Rrna Gene ◽  
Peptic Ulcers ◽  
Gastric Cancer Stem Cells ◽  
H Pylori

Background and aim: Helicobacter pylori (H. pylori) is an incriminated pathogen causing diseases in both animals and humans and considered a zoonotic pathogen. H. pylori infection is considered a cause of gastric cancer, which rests a significant health care challenge. This study analyzes the expression pattern of matrix metalloprotein 2 (MMP-2) in patients with Helicobacter pylori-associated gastritis and the effect of H. pylori on gastric cancer stem cells, as well as study the role of helicon bacteriosis in dog in transmission of H. pylori infection to human. Materials and methods: Fifty-five of each sample (gastric biopsy, blood and stool) were collected from patients suffering from dyspepsia, chronic vomiting and perforated peptic ulcers and also from apparent healthy dogs. The investigation detected H. pylori by serological and histopathological examination. Biopsies were stored in physiological saline for identification of H. pylori by conventional time PCR. MMP-2 and Gastric cancer stem cells were then identified by immunohistochemistry. Results: Serological identification for H. pylori Antigen and Antibodies revealed (63% human, 50% dogs) and (87% human, 90% dogs) respectively were positive. Genotyping of H. pylori based on 16S rRNA gene showed 54.5% of human and 35% of dogs were positive. Immunohistochemistry revealed strong expression of CD44 in H. pylori- associated gastric cancer cases, MMP-2 expression was observed in all neoplastic lesions associated with H. pylori infection. Conclusion: H. pylori infection affects gastric mucosa and induces changes in gastric stem cells altering their differentiation and increased expression of MMP’s and CD44with a resultant potentiation of oncogenic alteration. In addition the up-regulation of both markers could be an instrumental to interpret the origination of gastric cancer.

Sign in / Sign up

Export Citation Format

Share Document